Barry Ritholtz says investors should not interfere with the magic of compounding – CNBC
According to Barry Ritholtz, chairman and chief investment officer at Ritholtz Wealth Management, investors often overlook the power of compound interest, which is a big mistake. Investors who follow broadly believe in compound interest benefits, and the ability to not only acquire benefits on principles but also gain reinvested profits in profits is key to […]
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk has asked the Food and Drug Administration (FDA) to block compounding pharmacies from selling proprietary versions of its popular weight loss drug Wigoby and diabetes drug Ozempic, saying the drugs are too complex for pharmacies to manufacture safely. We are asking them to stop their production. Compounded anti-obesity drugs are sold at significantly […]